Timolol

Timolol microdrops administered with the Nanodropper Adaptor were as effective as conventional drops at lowering IOP among patients with open-angle glaucoma and ocular hypertension, according to a study published in Ophthalmology.

CHICAGO — Once-daily sepetaprost was noninferior to twice-daily timolol in reducing IOP in patients with primary open-angle glaucoma or ocular hypertension, according to a study presented at the American Academy of Ophthalmology meeting.

Théa has agreed to purchase seven branded ophthalmic products from Akorn, according to a press release.

The iDose TR demonstrated sustained IOP reduction at 36 months, according to a press release from Glaukos.

Recent blogs on Healio/OSN include an explanation of patient payments for Cequa and a look at timolol in glaucoma treatment.

We are extremely fortunate to have a number of efficacious and relatively safe medical therapies to choose from when treating our patients with ocular hypertension and glaucoma.

Timolol may be an effective and inexpensive treatment for wound healing, according to a poster presented at AAD VMX 2021.

Betaliq has enrolled the first patient in a phase 2 trial investigating BTQ-1901 and BTQ-1902 for the treatment of glaucoma or ocular hypertension, according to a press release.

Topical timolol, while well tolerated, offered little efficacy in treating early proliferative infantile hemangioma, according to a study.

Dry eye disease and glaucoma both increase in prevalence with age. They are also commonly present in the patient who presents for cataract surgery.